Aminaphtone for use in the treatment and/or prevention of migraine
EP2799074A1
Iron bis-glycinate chelate for use in the oral treatment of anemia in patients with celiac disease
EP2403495A1
Metadoxine for use as inhibitor of hepatic fibrosis.
EP2335695A1
Use of aminapthone for the preparation of a medicament for treating arteriophaties
AU1031697A
Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions
EP0769298A2
Pharmaceutical compositions for topical use containing hyaluronic acid and Döderlein's bacillus for the prevention and treatment of vaginal diseases
WO9418965A1
Therapeutic use of pyridoxine pyrrolidone carboxylate
US5594110A
Process of conjugation of antiviral nucleosides with lactosaminated human albumin
ITMI931082D0
ANTI-VIRAL DRUG CONJUGATES WITH HEPATOTROPIC ACTIVITY, RELATED VEHICLES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
KR100257967B1
Process for the preparation of pyridoxine 5-oxo-2-pyrrolidone carboxylate
EP0503741A1
Conjugate of azidothymidine and human albumin, process for its preparation and pharmaceutical compositions containing it
EP0482540A1
Novel derivatives of corticosteroids, process for their preparation and pharmaceutical composition containing them
EP0509120A1
Topical use of glycosaminoglycans in the prevention and treatment of diseases affecting the cervical vaginal tract
ITMI911058D0
Use of pyridoxine pyrrolidonecarboxylate for the treatment of depressive affective disorders
EP0307879A2
Sulfonamido derivatives inhibiting the aldose reductase enzyme system and pharmaceutical compositions containing them
US4725672A
Conjugate of 9-(2-hydroxyethoxymethyl)-guanine with lactosaminated human albumin, process for the preparation thereof and pharmaceutical compositions containing it
CA1252719A
METHOD FOR THE PREPARATION OF CONJUGATES OF ADENINE-9- .beta.-ARABINOFURANOSIDE 5' MONOPHOSPHATE WITH LACTOSAMINATED HUMAN ALBUMIN, THE CONJUGATES OBTAINED AND THERAPEUTICALLY ACTIVE COMPOSITION CONTAINING THEM
EP0175304A2
Compounds derived from beta-oximino-propionic acid having therapeutic activity, process for their preparation, and pharmaceutical compositions containing them
